Index RUT P/E 22.56 EPS (ttm) 2.66 Insider Own 2.45% Shs Outstand 42.31M Perf Week 20.93%
Market Cap 2.26B Forward P/E 10.63 EPS next Y 5.65 Insider Trans -28.48% Shs Float 36.69M Perf Month 18.45%
Income 109.60M PEG 1.50 EPS next Q 1.28 Inst Own 104.75% Short Float 5.30% Perf Quarter 24.16%
Sales 1.54B P/S 1.47 EPS this Y 17.10% Inst Trans -2.79% Short Ratio 4.54 Perf Half Y 11.99%
Book/sh 34.98 P/B 1.72 EPS next Y 14.60% ROA 3.96% Short Interest 1.94M Perf Year 40.90%
Cash/sh 5.35 P/C 11.22 EPS next 5Y 15.00% ROE 7.82% 52W Range 33.59 - 62.99 Perf YTD 1.92%
Dividend Est. - P/FCF 9.47 EPS past 5Y 31.53% ROI 5.15% 52W High -4.62% Beta 0.89
Dividend TTM - Quick Ratio 0.76 Sales past 5Y 5.87% Gross Margin 55.53% 52W Low 78.86% ATR (14) 2.03
Dividend Ex-Date Nov 30, 2016 Current Ratio 0.76 EPS Y/Y TTM 46.03% Oper. Margin 14.81% RSI (14) 83.75 Volatility 5.37% 3.15%
Employees 9655 Debt/Eq 0.64 Sales Y/Y TTM 6.30% Profit Margin 7.12% Recom 1.33 Target Price 68.33
Option/Short Yes / Yes LT Debt/Eq 0.61 EPS Q/Q -8.05% Payout 0.00% Rel Volume 2.67 Prev Close 52.40
Sales Surprise 5.36% EPS Surprise 29.86% Sales Q/Q 11.81% Earnings May 02 AMC Avg Volume 428.44K Price 60.08
SMA20 25.24% SMA50 22.76% SMA200 20.57% Trades
Volume 1,144,803 Change 14.66%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-27-23 Upgrade Robert W. Baird
Neutral → Outperform
$47 → $55
Jul-07-23 Upgrade BMO Capital Markets
Market Perform → Outperform
$44
Aug-23-21 Resumed BMO Capital Markets
Market Perform
$40
Sep-12-19 Initiated Sidoti
Buy
May-03-24 12:29PM
11:21AM
07:17AM
(Thomson Reuters StreetEvents)
04:10AM
May-02-24 09:55PM
05:43PM
Loading…
05:43PM
04:57PM
(Associated Press Finance)
04:48PM
04:15PM
May-01-24 03:12AM
Apr-22-24 08:30AM
02:34AM
Apr-17-24 03:40AM
Mar-25-24 08:30AM
Mar-21-24 12:38PM
07:07AM
Loading…
07:07AM
Mar-13-24 08:00AM
Mar-11-24 06:39AM
Mar-01-24 10:18AM
Feb-29-24 11:30AM
Feb-28-24 10:21AM
Feb-22-24 09:35AM
08:00AM
Feb-13-24 08:00AM
Feb-08-24 09:00PM
10:59AM
Feb-06-24 01:00PM
Feb-02-24 09:40AM
09:35AM
Feb-01-24 01:52PM
02:35PM
Loading…
Jan-31-24 02:35PM
12:41PM
07:04AM
(Thomson Reuters StreetEvents)
06:42AM
Jan-30-24 06:45PM
05:54PM
05:40PM
(Associated Press Finance)
05:31PM
12:20PM
09:50AM
Jan-19-24 07:57PM
08:00AM
Jan-09-24 09:00AM
Jan-02-24 09:00AM
Dec-12-23 05:05PM
Dec-06-23 09:40AM
Nov-29-23 06:42AM
Nov-15-23 09:15AM
Nov-14-23 09:00AM
Nov-13-23 11:03PM
Nov-03-23 11:43AM
Nov-02-23 10:21AM
Oct-31-23 09:40AM
09:40AM
08:50AM
Oct-30-23 09:15AM
Oct-27-23 12:10PM
(Investor's Business Daily) +15.83%
12:03PM
12:01PM
09:59AM
Oct-26-23 05:44PM
05:40PM
04:38PM
(Associated Press Finance)
04:10PM
Oct-23-23 11:40AM
Oct-16-23 11:04AM
Oct-12-23 09:40AM
08:09AM
Oct-11-23 11:55AM
Oct-06-23 11:40AM
Oct-05-23 06:17AM
Oct-04-23 10:07AM
Oct-03-23 09:00AM
Sep-29-23 08:24AM
Sep-20-23 11:40AM
Sep-19-23 09:40AM
Sep-13-23 01:19PM
09:40AM
Sep-12-23 08:56AM
08:30AM
07:30AM
Sep-11-23 11:45AM
Sep-05-23 08:50AM
Sep-04-23 12:38PM
11:40AM
Aug-28-23 09:40AM
Aug-23-23 09:26AM
Aug-22-23 11:13AM
09:00AM
Aug-15-23 08:00AM
Aug-13-23 05:19AM
Aug-11-23 11:27AM
06:52AM
(Thomson Reuters StreetEvents)
Aug-10-23 06:55PM
05:55PM
Aug-08-23 05:50PM
Aug-07-23 09:25AM
Jul-24-23 05:00AM
Jul-21-23 11:35AM
Jul-13-23 09:00AM
Adtalem Global Education, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Herrera Maurice SVP - Chief Marketing Officer Dec 08 '23 Sale 60.00 4,200 252,000 24,519 Dec 11 04:26 PM Simpson Blake SVP, Chief Comms Officer Dec 06 '23 Sale 59.23 550 32,577 7,986 Dec 07 04:55 PM WARDELL LISA W Director Nov 14 '23 Option Exercise 33.90 4,643 157,398 166,777 Nov 15 04:14 PM WARDELL LISA W Director Nov 14 '23 Sale 55.77 4,643 258,936 162,134 Nov 15 04:14 PM WARDELL LISA W Director Nov 13 '23 Option Exercise 33.90 62,757 2,127,462 224,891 Nov 15 04:14 PM WARDELL LISA W Director Nov 13 '23 Sale 54.77 62,757 3,437,326 162,134 Nov 15 04:14 PM WARDELL LISA W Director Nov 10 '23 Option Exercise 33.90 49,478 1,677,304 211,612 Nov 13 04:26 PM WARDELL LISA W Director Nov 10 '23 Sale 55.19 49,478 2,730,483 162,134 Nov 13 04:26 PM WARDELL LISA W Director Nov 09 '23 Option Exercise 33.90 78,570 2,663,523 242,338 Nov 13 04:26 PM WARDELL LISA W Director Nov 09 '23 Sale 55.57 78,570 4,366,103 163,768 Nov 13 04:26 PM WARDELL LISA W Director Nov 08 '23 Option Exercise 33.90 45,623 1,546,620 206,861 Nov 13 04:26 PM WARDELL LISA W Director Nov 08 '23 Sale 55.15 45,623 2,516,268 161,238 Nov 13 04:26 PM WARDELL LISA W Director Nov 07 '23 Option Exercise 33.90 71,722 2,431,376 232,960 Nov 07 06:01 PM WARDELL LISA W Director Nov 07 '23 Sale 55.30 71,722 3,966,384 161,238 Nov 07 06:01 PM WARDELL LISA W Director Nov 06 '23 Option Exercise 33.90 20,233 685,899 181,471 Nov 07 06:01 PM WARDELL LISA W Director Nov 06 '23 Sale 55.01 20,233 1,113,003 161,238 Nov 07 06:01 PM WARDELL LISA W Director Nov 03 '23 Sale 55.02 29,172 1,605,006 161,238 Nov 07 06:01 PM Gangadharan Manjunath VP, Chief Accounting Officer Aug 28 '23 Sale 43.45 1,418 61,614 7,420 Aug 29 04:14 PM BURKE WILLIAM W Director Aug 14 '23 Sale 43.60 1,500 65,400 13,271 Aug 15 04:26 PM WARDELL LISA W Director May 15 '23 Sale 40.45 71,400 2,887,830 180,034 May 16 04:25 PM WARDELL LISA W Director May 12 '23 Sale 41.14 24,094 991,328 251,434 May 16 04:25 PM WARDELL LISA W Director May 11 '23 Sale 41.24 7,940 327,476 275,528 May 12 04:14 PM
Index RUT P/E 12.02 EPS (ttm) 1.19 Insider Own 2.64% Shs Outstand 23.60M Perf Week -0.17%
Market Cap 339.17M Forward P/E 15.39 EPS next Y 0.93 Insider Trans -3.58% Shs Float 23.13M Perf Month -6.39%
Income 28.52M PEG 2.40 EPS next Q -0.08 Inst Own 87.20% Short Float 4.90% Perf Quarter -6.15%
Sales 274.42M P/S 1.24 EPS this Y -55.43% Inst Trans -1.74% Short Ratio 3.92 Perf Half Y 21.90%
Book/sh 8.20 P/B 1.74 EPS next Y 63.44% ROA 10.51% Short Interest 1.13M Perf Year -23.83%
Cash/sh 2.57 P/C 5.56 EPS next 5Y 5.00% ROE 18.10% 52W Range 9.69 - 26.11 Perf YTD -0.17%
Dividend Est. - P/FCF 10.15 EPS past 5Y 29.16% ROI 11.97% 52W High -45.33% Beta 1.26
Dividend TTM - Quick Ratio 2.99 Sales past 5Y 14.31% Gross Margin 69.61% 52W Low 47.24% ATR (14) 0.60
Dividend Ex-Date - Current Ratio 3.54 EPS Y/Y TTM 234.10% Oper. Margin 5.35% RSI (14) 44.25 Volatility 3.57% 3.98%
Employees 992 Debt/Eq 0.26 Sales Y/Y TTM 11.20% Profit Margin 10.39% Recom 1.00 Target Price 20.67
Option/Short Yes / Yes LT Debt/Eq 0.23 EPS Q/Q 51.52% Payout 0.00% Rel Volume 0.45 Prev Close 14.44
Sales Surprise -0.88% EPS Surprise 79.32% Sales Q/Q 5.08% Earnings May 06 AMC Avg Volume 289.01K Price 14.27
SMA20 -2.40% SMA50 -6.66% SMA200 -5.77% Trades
Volume 128,796 Change -1.14%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-13-20 Upgrade Oppenheimer
Perform → Outperform
$55
Oct-22-19 Initiated Oppenheimer
Perform
Aug-07-19 Upgrade BTIG Research
Neutral → Buy
$62
Jun-13-19 Initiated Dougherty & Company
Buy
$80
Jan-02-19 Upgrade Northland Capital
Under Perform → Market Perform
Jun-04-18 Downgrade Northland Capital
Market Perform → Under Perform
Feb-27-18 Downgrade Northland Capital
Outperform → Market Perform
Dec-08-17 Initiated Sidoti
Neutral
Nov-09-17 Upgrade BTIG Research
Neutral → Buy
Oct-12-17 Initiated Guggenheim
Buy
$47
May-02-24 05:45PM
09:00AM
Apr-26-24 05:45PM
Apr-24-24 07:09AM
Apr-23-24 04:05PM
09:30AM
Loading…
09:30AM
Apr-18-24 05:45PM
Apr-17-24 09:40AM
09:00AM
Apr-15-24 04:05PM
Apr-12-24 05:45PM
01:53PM
Apr-03-24 12:00PM
Apr-01-24 09:40AM
Mar-14-24 09:40AM
09:55AM
Loading…
Mar-13-24 09:55AM
Feb-27-24 09:40AM
Feb-26-24 09:55AM
Feb-23-24 09:55AM
Feb-21-24 09:26AM
Feb-20-24 10:39PM
(Thomson Reuters StreetEvents)
06:34PM
08:40AM
08:11AM
07:38AM
(Associated Press Finance)
07:30AM
Feb-05-24 04:05PM
Feb-01-24 06:51PM
Jan-29-24 07:30AM
Nov-08-23 07:30AM
10:38AM
Loading…
Nov-07-23 10:38AM
10:08AM
(Thomson Reuters StreetEvents)
Nov-06-23 05:44PM
05:03PM
(Associated Press Finance)
04:05PM
Nov-03-23 08:46AM
Oct-03-23 07:30AM
Oct-02-23 04:05AM
Sep-25-23 08:38AM
Sep-19-23 09:00AM
Sep-07-23 07:30AM
Aug-31-23 04:05PM
Aug-10-23 05:41AM
Aug-07-23 06:05PM
04:58PM
04:05PM
Jul-28-23 09:25PM
Jul-21-23 12:19PM
Jul-18-23 08:00AM
Jul-07-23 12:10PM
Jun-29-23 04:05PM
Jun-09-23 11:48AM
May-26-23 11:18AM
May-23-23 07:30AM
May-10-23 06:10AM
May-09-23 10:52AM
10:42AM
(Thomson Reuters StreetEvents)
May-08-23 05:55PM
04:53PM
04:05PM
May-03-23 09:57AM
Mar-30-23 04:05PM
Mar-20-23 02:00PM
Mar-14-23 09:00AM
Mar-02-23 04:05PM
Feb-23-23 09:25PM
04:01PM
Feb-22-23 05:50AM
(Simply Wall St.) +10.73%
Feb-21-23 11:22PM
(Thomson Reuters StreetEvents) -7.56%
08:25AM
07:07AM
06:59AM
Feb-01-23 07:30AM
Jan-22-23 08:06AM
Jan-05-23 07:30AM
Jan-03-23 08:42AM
Dec-28-22 08:50AM
Dec-22-22 08:54AM
Dec-21-22 09:08AM
Dec-12-22 05:25AM
Nov-29-22 08:55AM
Nov-28-22 09:55AM
08:27AM
Nov-22-22 04:05PM
Nov-21-22 04:05PM
Nov-10-22 09:55AM
Nov-07-22 06:05PM
04:05PM
Sep-29-22 05:25AM
Sep-26-22 07:30AM
Sep-06-22 07:30AM
Aug-01-22 05:55PM
04:05PM
Jul-25-22 07:30AM
Jul-12-22 04:05PM
Jul-04-22 12:04PM
Jun-07-22 07:30AM
Jun-03-22 07:21PM
May-25-22 04:05PM
11:34AM
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
REUVERS DANIEL L. President and CEO Feb 29 '24 Sale 15.25 1,396 21,289 238,027 Feb 29 08:42 PM Burns Kristie Sr. VP Mktg & Clinical Affairs Feb 29 '24 Sale 15.25 243 3,706 63,389 Feb 29 08:43 PM REUVERS DANIEL L. President and CEO Feb 27 '24 Sale 15.60 4,689 73,148 239,423 Feb 29 08:42 PM Burns Kristie Sr. VP Mktg & Clinical Affairs Feb 27 '24 Sale 15.58 1,091 17,001 63,632 Feb 29 08:43 PM REUVERS DANIEL L. President and CEO Feb 26 '24 Sale 15.81 6,239 98,645 244,112 Feb 27 09:13 PM Burns Kristie Sr. VP Mktg & Clinical Affairs Feb 26 '24 Sale 15.90 2,015 32,049 63,512 Feb 27 09:12 PM REUVERS DANIEL L. President and CEO Feb 23 '24 Sale 14.85 5,378 79,853 192,321 Feb 27 09:13 PM Burns Kristie Sr. VP Mktg & Clinical Affairs Feb 23 '24 Sale 14.80 2,249 33,278 53,765 Feb 27 09:12 PM REUVERS DANIEL L. President and CEO Aug 07 '23 Sale 20.53 1,062 21,808 125,653 Aug 09 04:10 PM BURKE WILLIAM W Director May 12 '23 Sale 21.86 4,400 96,184 27,773 May 16 05:52 PM Burns Kristie Sr. VP Mktg & Clinical Affairs May 08 '23 Sale 18.65 786 14,659 36,562 May 10 04:18 PM PAULS ERIC Senior VP, Sales May 08 '23 Sale 18.55 550 10,200 29,498 May 10 04:17 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
